Clinical Trial Update: A Study Evaluating The Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgically Resectable Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

Hoffmann-La Roche sponsored a Phase 1/2 trial evaluating neoadjuvant immunotherapy combinations in patients with surgically resectable hepatocellular carcinoma;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Carcinoma, Hepatocellular | Phase 1, Phase 2 | Status: COMPLETED